Spineology has launched OptiMesh Align, a biologics-based solution for real time, in-situ, independent anterior and posterior implant expansion that results in a customized, patient-specific lordotic shape up to 20 degrees.

Its expansion method was designed to surmount limitations and reduce point-loading typically seen with mechanically expandable implant technology. Since OptiMesh is delivered through one of the smallest insertion points available and expands to one of the largest implant footprints—according to Spineology—it allows correction not usually associated with minimally invasive posterior spine approaches.

OptiMesh Align was also engineered to produce distraction forces and endplate conformance. It provides strength and strength and stability to restore disc height, creates a robust fusion scaffold, and now supports achieving sagittal alignment objectives, the company said.

“Sagittal alignment is widely considered one of the key correlative indicators to achieving long term clinical success for spine patients. The OptiMesh technology remains the only conforming expandable implant that offers a personalized solution for each patient,” said Brian Snider, Spineology’s CEO. “With the addition of the lordotic capabilities of the Align implant, our portfolio provides more options to achieve the clinical requirements of surgery.”

In September 2024, the company unveiled a new brand and visual identity, logo, and product positioning as part of an extensive branding initiative.